PRESIDENT OF MIRADOR
Jamie BLACKPORT, Founder and President
Jamie has a 20+ year commercial and medical affairs global pharmaceutical career and specializes in successfully helping small and mid-sized biopharma companies commercially develop, transact, and launch products worldwide. He started Mirador Analytics with the fellow founders as they saw health care organizations needed support to realize the full potential of their data and analyses. Offering that support would, in turn, help support innovation and growth in the industry and advance global health care. |
OPERATIONS AND SERVICE DELIVERY
Jamie GRAY, Chief Operating Officer
As COO, Jamie is responsible for all of Mirador's operational activities and also manages our client services functions. His role includes building and coordinating the implementation of new business processes and strategies across functions to grow the organization effectively. His roles also include the coordination of our marketing, brand strategy, and communications efforts. Jamie has been with Mirador Analytics since its founding and has an in-depth knowledge of the company's past, present, and future activities. He has held various roles during this time, both customer-facing and behind-the-scenes developing infrastructure. |
PARTNERSHIPS |
DATA ANALYSIS AND STATISTICS
Colin MOFFATT, Chief Data Scientist and Privacy Expert
PhD, MSc, MRes, BSc (Hons), DIC, FHEA, GradStat Colin is our Chief Data Scientist and statistician. He oversees and works on our statistical risk analyses and also builds completed reports. Colin has 20 years' experience in statistics and data analysis, having analyzed the data for over 30 scientific publications and taught applied statistics to university students of all levels. He is a Fellow of the Royal Statistical Society with GradStat status and has an MSc in Data Science from Lancaster University. He has expertise in a variety of methods in statistical modeling, machine learning, and data mining, being a long-time user of the software R. Colin's background is in applied biology, in which he holds a PhD from Imperial College London and an MRes from Lancaster University. He has been a regular reviewer of submissions to several scientific journals and is an honorary lecturer at De Montfort University, Leicester.
|
Kirsty MACRUARY, Principal Data Scientist & Privacy Expert
PhD, BSc (Hons) Kirsty is a Principal Data Scientist within the Privacy Hub Expert Services team. Having performed an extensive number of statistical disclosure risk assessments during her time at Mirador Analytics, she now focuses on thought leadership and supporting the wider Privacy Expert team with her knowledge across a variety of health data compliance projects.
She has experience in diverse and complex analysis, ranging from unstructured data, process reports and collaborating on new frameworks for re-identification risk advice. During her time as a Data Scientist, she has gained a keen interest in privacy and data protection and enjoys discussing the nuances of regulations with the team. Prior to joining Mirador Analytics in September 2018 she worked in both health care and finance data after completing her PhD in computational chemistry at the University of Edinburgh. |
Lisa PATRICK, Principal Data Scientist & Privacy Expert
PhD, MChem (Hons) Lisa is a Principal Data Scientist and her role involves leadership and support of the Privacy Expert data science team including the development of guidance and assessment of quality standards within the team. Within her time at Mirador Analytics, she has worked on a wide range of privacy projects, completing a large number of Expert Determination assessments and other varied privacy related work, as well as contributing to the advice and solutions for privacy and data analysis used by the team.
Prior to joining Mirador Analytics, Lisa's background is in Chemistry, and she completed a MChem at Heriot-Watt University which included a year placement in synthetic chemistry with pharmaceutical company Boehringer Ingelheim. Following this, she completed a PhD at the University of Edinburgh, working in the field of structure-based drug design, which was in collaboration with the pharmaceutical company UCB. |